Form 8-K - Current report:
SEC Accession No. 0001615219-20-000126
Filing Date
2020-12-11
Accepted
2020-12-11 08:28:54
Documents
3
Period of Report
2020-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K slrx8-k12112020.htm 8-K 24966
2 EX-4.1 slrx-formofinducementw.htm EX-4.1 138108
3 EX-10.1 slrx-warrantrepricelet.htm EX-10.1 67930
  Complete submission text file 0001615219-20-000126.txt   232368
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 201382305
SIC: 2834 Pharmaceutical Preparations